MIR518C: A Potential Drug Target and Biomarker (G574477)

Target Name: MIR518C

NCBI ID: G574477

MIR518C

MIR518C: A Potential Drug Target and Biomarker

MIR518C, a non-coding RNA molecule, has been identified as a potential drug target and biomarker in various diseases, including cancer, neurodegenerative diseases, and autoimmune disorders. Its unique structure and diverse functions make it an attractive target for drug development, and various studies have shown its potential in modulating gene expression and cellular behavior.

MIR518C is a small non-coding RNA molecule, which is approximately 200 nucleotides in length. It is expressed in various tissues and cells of the body and is involved in various cellular processes, including cell growth, differentiation, and RNA homeostasis. MIR518C is a good candidate for a drug target because of its unique structure, which allows it to interact with various signaling pathways and target molecules.

One of the key features of MIR518C is its ability to interact with the microRNA (miRNA) machinery. miRNA is a small non-coding RNA molecule that plays a critical role in post-transcriptional gene regulation by binding to specific mRNAs to promote or repress their translation or degradation. MIR518C has been shown to interact with several known miRNAs, including miR-18a, miR-30a, and miR-128, which are involved in various cellular processes, including cell growth, apoptosis, and inflammation.

MIR518C's interaction with miR-18a and miR-30a suggests that it may be a target for drugs that are able to modify the activity of these miRNAs. Specifically, MIR518C may be a drug that can increase the levels of miR-18a and/or miR-30a in cells, which could lead to increased cell proliferation, apoptosis, or inflammation.

Another potential mechanism by which MIR518C may be a drug target is its role in the regulation of cellular apoptosis. MIR518C has been shown to play a critical role in regulating cell apoptosis in various cell types, including cancer cells. Its interaction with miR-18a and miR-30a suggests that it may be a target for drugs that are able to modify the activity of these miRNAs, which could lead to increased or decreased cell apoptosis.

MIR518C's role in cell apoptosis may also be a potential biomarker for certain diseases. For example, MIR518C has been shown to be downregulated in various types of cancer, which may indicate that these cancers are less susceptible to certain therapies that target MIR518C. Additionally, MIR518C has been shown to be involved in the regulation of cellular inflammation, which may be a potential biomarker for certain types of autoimmune disorders.

In conclusion, MIR518C is a unique and promising candidate for drug development as a potential drug target and biomarker. Its interaction with the miRNA machinery and its role in cell apoptosis and inflammation make it an attractive target for drug development in various diseases. Further research is needed to fully understand the mechanisms of MIR518C's function and its potential as a drug target and biomarker.

Protein Name: MicroRNA 518c

The "MIR518C Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about MIR518C comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets